AIDS News and Research

RSS

Emerging Pandemic Threats program to combat newly emerging diseases of animal origin

The United States Agency for International Development (USAID) is launching an Emerging Pandemic Threats (EPT) program that builds on the successes of the Agency's long-standing programs in disease surveillance, training, and outbreak response, particularly those addressing avian and pandemic influenza.

22 Oct 2009

AHF commends Congress for its passage of the Ryan White CARE Act

AIDS Healthcare Foundation (AHF), the largest global AIDS organization which provides services to more than 129,000 people in the US, Africa, Latin America/Caribbean and Asia, today commended Congress for its passage of the Ryan White CARE Act (RWCA, or the CARE Act), the federal law that provides the primary source of funding for AIDS care and services nationwide. The bill cleared the Senate on Monday by unanimous consent and passed the House earlier today by a 408 to 9 vote.

22 Oct 2009

HIV stigma: a barrier for proper care

The feeling of stigmatization that people living with HIV often experience doesn't only exact a psychological toll -new UCLA research suggests it can also lead to quantifiably negative health outcomes.

22 Oct 2009

Media outlets examine how AIDS vaccine trial results will shape future studies

As the AIDS vaccine conference continues in Paris this week, Reuters examines how recent trials are helping researchers better understand ways to develop a vaccine that offers people protection from HIV.

22 Oct 2009

Guardian examines how Uganda's drought, food shortages affect HIV-positive people

The Guardian examines how "famine and acute food shortages" in Uganda could affect people living with HIV/AIDS. "The situation is beginning to undermine efforts to fight the virus in the north and east of Uganda, the areas most affected by the drought," according to the Guardian.

22 Oct 2009

U.S. Congress extends Ryan White HIV/AIDS Program, HIV care providers applaud move

Medical providers on the front lines of HIV care applaud the U.S. Congress for extending the Ryan White HIV/AIDS Program, helping to ensure that more than half a million low-income, uninsured, or underinsured people living with HIV/AIDS have access to lifesaving care.

22 Oct 2009

Crux Biomedical receives U.S. patent for its novel vena cava filter

Crux Biomedical Inc. announced today that it was awarded a U.S. patent, (US 7,582,100 B2), for its novel vena cava filter.

22 Oct 2009

Also in Global Health News: Nigeria Global Fund grant; Pakistani refugees; Guinea violence

The Global Fund to Fight AIDS, Tuberculosis and Malaria awarded Nigeria a $669 million Round 8 grant for health system strengthening over five years, This Day/allAfrica.com reports. "During the grant signing ceremony in Abuja yesterday, Chairman of the occasion and former Head of State, General Yakubu Gowon, disclosed that the [The Global Fund] had spent $15.6 billion in 140 countries worldwide especially in Africa to support large scale prevention treatment and care programmes against these diseases.

22 Oct 2009

EU policies threaten developing countries drug supplies, report says

A report, released Tuesday, from Oxfam International and Health Action International says the EU is putting big drug companies' interests ahead of "millions of people" in developing countries who do not have access to essential medicines, Agence France-Presse reports (10/20).

22 Oct 2009

AIDS vaccine not as effective as first thought, scientists say

A vaccine to protect against HIV may not be as effective as first thought, scientists said Tuesday.

22 Oct 2009

106m infants worldwide received vaccines last year, coverage gaps remain, report says

A joint report by the WHO, UNICEF and the World Bank on worldwide vaccination efforts released Wednesday found "a record 106 million infants were vaccinated last year against life-threatening diseases, but nearly a fifth of the world's babies still are not protected fully," the Associated Press reports.

22 Oct 2009

Positive results from Argos Therapeutics' personalized immunotherapy candidate AGS-004 Phase 2a trial

Argos Therapeutics today announced two presentations at the AIDS Vaccine 2009 conference, detailing positive viral load, immune response and safety data from an ongoing Phase 2a trial of AGS-004, its personalized immunotherapy candidate. AGS-004 is a product of the Company’s Arcelis™ technology, and is a personalized, RNA-loaded, dendritic cell-based immunotherapy that is perfectly matched to each patient’s unique HIV viral burden.

21 Oct 2009

Study on childhood risk factors for the development of future substance use disorders

There is ample evidence for the genetic influence of alcohol dependence, and ongoing studies are actively looking for specific genes that may confer this increased susceptibility. In addition, while it is well-known that individual risk is increased with the number of relatives with alcohol dependence, scientists have not been in a position to identify who among these individuals might have greater or lesser risk.

21 Oct 2009

V8 100% vegetable juice aids in weight loss and lowers blood pressure

Decades of studies have documented the link between eating a diet rich in vegetables and multiple health benefits, yet nearly eight out of 10 people worldwide fall short of the daily recommendation.

21 Oct 2009

Amputation prevention tips for diabetic patients

While "One Foot, Two Foot, Red Foot, Blue Foot" may be the opening line of a humorous children's book by Dr. Seuss, foot complications are no laughing matter to the 20 million Americans with diabetes. According to the American Orthopaedic Foot & Ankle Society (AOFAS), ulceration, infection, and gangrene are the most common foot and ankle problems of the diabetic patient.

21 Oct 2009

Also in Global Health News: Cholera in Zimbabwe; personal computers; medical 'outliers'; rain in Kenya; generic drugs

A cholera outbreak in Zimbabwe has infected more than 100, resulting in five deaths, state media said Tuesday, Reuters reports, "raising fears of a repeat of last year's epidemic that claimed more than 4,000 lives.

21 Oct 2009

Inovio Biomedical highlights its advances in SynCon DNA vaccines

Inovio Biomedical Corporation, a leader in DNA vaccine design, development and delivery, announced that Dr. David B. Weiner, Chairman of Inovio’s Scientific Advisory Board, highlighted advances in electroporation-delivered SynCon™ DNA vaccines compared to other leading vaccine technologies at the AIDS Vaccine 2009 Conference being held this week in Paris, France.

21 Oct 2009

As HIV vaccine conference opens, experts appeal for sustained commitment to global fight against disease

Experts, gathered for the start of a four-day conference on HIV vaccines in Paris, called upon donors to maintain their funding support for the fight against HIV/AIDS despite the global economy, Agence France-Presse reports.

20 Oct 2009

Human Rights and Oversight to hold a hearing on international violence against women

On Wednesday, October 21 at 2:00 p.m. in Rayburn House Office Building, Room 2172, Chairman Delahunt (D-MA) of the House Foreign Affairs Subcommittee on International Organizations, Human Rights and Oversight will hold a hearing titled International Violence Against Women: Stories and Solutions.

20 Oct 2009

Merck Frosst Canada announces the use of ISENTRESS for treating HIV-1 infected adults

Merck Frosst Canada Ltd. is pleased to announce that (Pr)ISENTRESS(R) (raltegravir) is now indicated for use in treatment-naïve HIV-1 infected adults in combination with other antiretroviral agents.

20 Oct 2009

AIDS News and Research

Emerging Pandemic Threats program to combat newly emerging diseases of animal origin

AHF commends Congress for its passage of the Ryan White CARE Act

HIV stigma: a barrier for proper care

Media outlets examine how AIDS vaccine trial results will shape future studies

Guardian examines how Uganda's drought, food shortages affect HIV-positive people

U.S. Congress extends Ryan White HIV/AIDS Program, HIV care providers applaud move

Crux Biomedical receives U.S. patent for its novel vena cava filter

Also in Global Health News: Nigeria Global Fund grant; Pakistani refugees; Guinea violence

EU policies threaten developing countries drug supplies, report says

AIDS vaccine not as effective as first thought, scientists say

106m infants worldwide received vaccines last year, coverage gaps remain, report says

Positive results from Argos Therapeutics' personalized immunotherapy candidate AGS-004 Phase 2a trial

Study on childhood risk factors for the development of future substance use disorders

V8 100% vegetable juice aids in weight loss and lowers blood pressure

Amputation prevention tips for diabetic patients

Also in Global Health News: Cholera in Zimbabwe; personal computers; medical 'outliers'; rain in Kenya; generic drugs

Inovio Biomedical highlights its advances in SynCon DNA vaccines

As HIV vaccine conference opens, experts appeal for sustained commitment to global fight against disease

Human Rights and Oversight to hold a hearing on international violence against women

Merck Frosst Canada announces the use of ISENTRESS for treating HIV-1 infected adults

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Exploring the G:Box and for high-quality imaging

Latest News